J. Domagala-Kulawik (Warsaw, Poland), R. Lazor (Lausanne, Switzerland), F. Bonella (Essen, Germany), C. Ravaglia (Castelbolognese, Italy)
Pulmonary Langerhans‘ cell histiocytosis (PLCH): A new UK register
R. Mason, N. Foley, H. Branley, T. Maher, M. Hetzel, H. Adamali, J. Suntharalingam (Taunton, Bath, Bristol, London, United Kingdom)
|   |
Pulmonary findings of the patients with Sjogren syndrome
S. Savas Bozbas, E.S. Akkurt, Z. Erayman Özen, S. Akcay (Ankara, Turkey)
| |
Characterization of 76 patients with lymphangioleiomyomatosis from a Brazilian reference center
C. Freitas, M. Araújo, B. Baldi, S. Pimenta, R. Kairalla, C.R. Carvalho (Sao Paulo, Brazil)
| |
Rate of FEV1 decline in lymphangioleiomyomatosis associated with tuberous sclerosis complex
R. Lazor, M. Reynaud-Gaubert, V. Cottin, J. Lacronique, C. Taillé, B. Wallaert, S. Hirschi, B. Crestani, J.F. Cordier, the Groupe d Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (Lausanne, Switzerland; Marseille, Lyon, Paris, Lille, Strasbourg, France)
| |
Effect of source of inhalation antigen on manifestation and prognosis of EAA patients
M. Sterclova, M. Vasakova, P. Paluch (Prague, Czech Republic)
| |
Diagnostic yield of specific inhalation challenge in patients with hypersensitivity pneumonitis
M. Sanchez, A. Villar, M.J. Cruz, F. Morell, X. Muñoz (Barcelona, Palma Mallorca, Spain)
| |
Computer tomography lung density in smokers is correlated to measures of local inflammation in the lung
R. Karimi, S. Nyren, A. Weelock, G. Tornling, M. Skold (Stockholm, Sweden)
| |
Different cutoff values of serum SP-D for German and Japanese to diagnose idiopathic interstitial pneumonias are related to different SFTPD gene polymorphisms
Y. Horimasu, N. Hattori, N. Ishikawa, S. Tanaka, K. Yoshioka, F. Bonella, S. Ohshimo, J. Guzman, U. Costabel, N. Kohno (Hiroshima, Japan; Bochum, Germany)
| |
Sarcoidosis associated pulmonary hypertension (SAPH) in the Netherlands
E. Bots, M. Wijsenbeek, L. van den Toorn, H. Hoogsteden, B. van den Blink (Rotterdam, Netherlands)
| |
The influence of TNFα gene polymorphism on the therapeutic response in patients with sarcoidosis
T. Pejcic, T. Radjenovic Petkovic, I. Stankovic, D. Nastasijevic Borovac, I. Djordjevic, Z. Ciric, M. Radovic (Nis, Republic Of Serbia)
| |
Determinants of fitness to fly in interstitial lung disease
H.K. Lota, S. Ward, C. Nelson, P. Sestini, T.M. Maher, A.U. Wells, E.A. Renzoni (London, United Kingdom; Siena, Italy)
| |
Diagnostic yield of transthoracic lung biopsy guided by CT in diffuse lung disease
M. Vaz, A. Morais, N. Melo, C. Souto Moura, J. Pereira, P. Mota (Porto, Portugal)
| |
CCL18 as marker of disease progression in systemic sclerosis
J. Schupp, G. Riemekasten, C. Kollert, B. Jäger, J. Müller-Quernheim, A. Prasse (Freiburg, Berlin, Germany)
| |
Abnormal heart rate variability in patients with sarcoidosis
E. Giallafos, V. Kouranos, A. Kalianos, G. Kaltsakas, I. Peros, D. Tsoukas, G. Dionelis, C. Kostopoulos, E. Stamboulis, N. Koulouris, A. Rapti (Athens, Nikaia, Greece)
| |
A prosprective study on the safety, tolerability and efficacy of pirfinidone in the treatment of idiopathic pulmonary fibrosis and fibrotic NSIP
R. Balakrishnan, S. Madas, B. Brasier, S. Rajan (Mumbai, Pune, India)
| |
Strong correlation between 18F-FDG PET positive bone involvement and increased IL-2R levels in patients with untreated sarcoidosis under surveillance (Preliminary results)
A. Kalkanis, D. Kalkanis, D. Drougas, N. Karagiannidis, D. Exarhos, I. Datseris, V. Polychronopoulos (Maroussi, Athens, Greece)
| |
Serum from patients with sarcoidosis promotes the proliferation of epithelial cell lines in vitro
I. Zampira, A. Gogali, P. Oikonomidis, E. Ntzani, A. Evagelou, F. Tachmatzoglou, M. Matthaiou, P. Canavaros, S. Constantopoulos, Y. Dalavanga (Ioannina, Greece)
| |
IL-17a expression in transbronchial biopsy samples in sarcoidosis
N. Köktürk, N. Akyürek, M. Aydogdu, A. Baha, H. Türktas (Ankara, Turkey)
| |
BALF TNFα level in relation to inflammatory status and phenotype of sarcoidosis
A. Goljan Geremek, M. Bednarek, E. Puscinska, M. Czystowska, M. Franczuk, I. Bestry, M. Filewska, M. Kram, U. Demkow, D. Górecka (Warsaw, Poland)
| |
Assessing sarcoidosis: The King‘s Sarcoidosis Questionnaire and the minimal important difference
A.S. Patel, A. Spinou, G. Keir, R.J. Siegert, T.M. Maher, E.A. Renzoni, A.U. Wells, I.J. Higginson, S.S. Birring (London, United Kingdom)
| |